Clinical Trial: Multicenter Randomized Double-Blind Study of VMX Eye Drops for Dry Eye Disease.

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07369375) titled 'Multicenter Randomized Double-Blind Study of VMX Eye Drops for Dry Eye Disease.' on Jan. 17.

Brief Summary: This multicenter, randomized, double-blind study evaluates the safety and effectiveness of VMX eye drops in patients with dry eye disease. It aims to improve tear film stability, reduce dry eye symptoms, and enhance patients' quality of life compared to standard treatment.

Study Start Date: Feb. 02

Study Type: INTERVENTIONAL

Condition: Dry Eye Disease (DED)

Intervention: DEVICE: VMX Eye Drops

VMX ophthalmic solution; the dosage is one drop in each eye three times a day for 56 days.

DEVICE: placebo eye drops

Sterile op...